News
Genolier Innovation Hub – A Pioneer in Medical Innovation
The Genolier Innovation Hub was inaugurated this Friday 27 September in canton of Vaud. With a CHF 100 million investment, the site aims at fostering innovation in healthcare in the Swiss Health Valley and internationally. Positioned next to the Genolier clinic, the 25,000 square-meter building is designed to encourage interdisciplinary collaboration between research, industry,…
Read Moreten23 health Opens State-of-the-Art VIVA2® Sterile Manufacturing Facility in Visp
This advanced, energy-efficient plant will enhance the company’s capabilities in commercial and clinical manufacturing of sterile medicines, including vials, syringes, and cartridges. The Swiss CDMO celebrates the grand opening of its VIVA2® facility in Visp. The facility adds two production lines: Line 2, designed for large-scale filling of ready-to-use containers, and Line 3,…
Read MoreAlithea Genomics Secures Loan from Swiss Technology Fund
Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics based in canton of Vaud, has received significant support from Switzerland’s Technology Fund in the form of a loan guarantee. The Technology Fund of the Swiss Federal Office for the Environment FOEN uses loan guarantees to support companies developing…
Read MoreNeo Medical completes a $68 million Series B financing round
Neo Medical SA (Neo), a Lausanne-Based technology company specialising in spine surgery, has announced the successful completion of its Series B financing round, including the conversion of existing shareholder loans. With this financing round, Neo has secured an additional equity investment of up to $68 million (CHF 58 million) to accelerate its global growth. …
Read MoreTWIICE and Nexco Analytics supported by the FIT
The Foundation for Technological Innovation extends its support to Twiice and Nexco Analytics with new loans. Twiice has been awarded a Tech Growth loan of CHF 400,000 for the development of its unique exoskeleton, and Nexco Analytic has been awarded a Tech Seed loan of CHF 100,000 for its software solution (Saas) to accelerate research processes…
Read MoreDigital twins for stroke victims
Hôpitaux universitaires de Genève (HUG) and Zurich University of Applied Sciences (ZHAW) will receive CHF 1.8 million from the Swiss Confederation and the EU to support a research project that aims to create digital twins of people who have suffered a stroke, in order to improve their personalised care. Stroke is a leading cause…
Read More8 startups selected for the Future of Health Grant
The Future of Health Grant received a record-breaking 213 applications in response to its 5th call for projects. These included submissions from around 100 international startups, demonstrating the programme’s growing reputation abroad. 8 promising projects were selected to join the programme. Level 1 Digehealth (Zurich) : offers a 24/7 monitoring device for bowel…
Read MoreDebiopharm lays the foundation stone for its new building
The new building will have a surface area of 3,500m2 dedicated to the creation of 150 to 300 flexible workstations. It will enable the company to expand and develop. The work will be completed in 2026. The building will also house a reservoir containing a total of 4.5 million litres of water, which…
Read MoreLatsis Prize: Prof. Mackenzie W. Mathis Awarded
Mackenzie W. Mathis, a professor at EPFL and winner of the Latsis 2024 Swiss Science Prize, is a pioneer in the application of artificial intelligence (AI) to behavioural neuroscience. Prof. Mathis research aims to understand the neural bases of learning and movement. She uses mice playing video games while recording their brain activity,…
Read MoreE-health: The Sense and ZS join forces
The Sense, a Swiss-based academic research and innovation centre, is teaming up with ZS, an international firm renowned for its expertise in healthcare, analytics, technology and research, to revolutionise clinical research and e-health. Their collaboration will focus on validating digital devices and therapies for regulatory approval, as well as conducting real-life studies to…
Read More